John Martin Docherty - Net Worth and Insider Trading
John Martin Docherty Net Worth
The estimated net worth of John Martin Docherty is at least $46,382 dollars as of 2024-11-13. John Martin Docherty is the President of Lexaria Bioscience Corp and owns about 20,166 shares of Lexaria Bioscience Corp (LEXX) stock worth over $46,382. Details can be seen in John Martin Docherty's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Martin Docherty has not made any transactions after 2016-04-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Martin Docherty
John Martin Docherty Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Martin Docherty owns 1 companies in total, including Lexaria Bioscience Corp (LEXX) .
Click here to see the complete history of John Martin Docherty’s form 4 insider trades.
Insider Ownership Summary of John Martin Docherty
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LEXX | Lexaria Bioscience Corp | 2016-04-15 | director & 10 percent owner |
John Martin Docherty Latest Holdings Summary
John Martin Docherty currently owns a total of 1 stock. John Martin Docherty owns 20,166 shares of Lexaria Bioscience Corp (LEXX) as of April 15, 2016, with a value of $46,382.
Latest Holdings of John Martin Docherty
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LEXX | Lexaria Bioscience Corp | 2016-04-15 | 20,166 | 2.30 | 46,382 |
Holding Weightings of John Martin Docherty
John Martin Docherty Form 4 Trading Tracker
According to the SEC Form 4 filings, John Martin Docherty has made a total of 0 transactions in Lexaria Bioscience Corp (LEXX) over the past 5 years. The most-recent trade in Lexaria Bioscience Corp is the acquisition of 7,000 shares on April 15, 2016, which cost John Martin Docherty around $21,000.
Insider Trading History of John Martin Docherty
- 1
John Martin Docherty Trading Performance
GuruFocus tracks the stock performance after each of John Martin Docherty's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Martin Docherty is 11.86%. GuruFocus also compares John Martin Docherty's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Martin Docherty within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John Martin Docherty's insider trading performs compared to the benchmark.
Performance of John Martin Docherty
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.58 | | | | | |
| Relative Return to S&P 500(%) | 4.47 | | | | | |
John Martin Docherty Ownership Network
Ownership Network List of John Martin Docherty
Ownership Network Relation of John Martin Docherty
John Martin Docherty Owned Company Details
What does Lexaria Bioscience Corp do?
Who are the key executives at Lexaria Bioscience Corp?
John Martin Docherty is the director & 10 percent owner of Lexaria Bioscience Corp. Other key executives at Lexaria Bioscience Corp include Secretary Vanessa Carle , Chief Financial Officer Gregory Downey , and director & 10 percent owner & CEO Christopher Bunka .
Lexaria Bioscience Corp (LEXX) Insider Trades Summary
Over the past 18 months, John Martin Docherty made no insider transaction in Lexaria Bioscience Corp (LEXX). Other recent insider transactions involving Lexaria Bioscience Corp (LEXX) include a net sale of 2,567 shares made by Vanessa Carle , and a net purchase of 1,600 shares made by Catherine C. Turkel .
In summary, during the past 3 months, insiders sold 0 shares of Lexaria Bioscience Corp (LEXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,567 shares of Lexaria Bioscience Corp (LEXX) were sold and 1,600 shares were bought by its insiders, resulting in a net sale of 967 shares.
Lexaria Bioscience Corp (LEXX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lexaria Bioscience Corp Insider Transactions
John Martin Docherty Mailing Address
Above is the net worth, insider trading, and ownership report for John Martin Docherty. You might contact John Martin Docherty via mailing address: 23 Mikelen Drive, Port Perry A6 L9l 1v1.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
